BD (NYSE: BDX) announced that Richard (Rick) Byrd will retire after nearly 25 years with the medical technology company, according to a statement released April 9.

Byrd currently serves as executive vice president and president of the Interventional Segment at BD, a position he has held since September 2022. During his tenure with the company, which began in 2004, Byrd held leadership roles including worldwide president of Medication Delivery Solutions and worldwide president of Preanalytical Systems.

Prior to joining BD, Byrd worked in various leadership and engineering positions across the medical device and advanced technology sectors.

"Over his long career, Rick has led his teams to deliver meaningful results for BD – strengthening our portfolio, elevating our operational rigor and advancing BD's role as a global healthcare leader," said Tom Polen, chairman, CEO and president of BD.

Polen noted Byrd's contributions across multiple segments, including expanding BD's leadership in Vascular Access Management, advancing the company's "One-Stick Hospital Stay" vision and leading manufacturing scale-up efforts during the COVID-19 pandemic.

Byrd will remain in his current role through June. BD plans to name a successor before his retirement date.

"What has inspired me most throughout my time at BD is the people – the teams who show up every day committed to driving the future of care and improving outcomes for patients everywhere," Byrd said. "I'm incredibly proud of the meaningful work we've accomplished together and am confident that BD will continue to deliver on its purpose of advancing the world of health."

BD operates globally with more than 60,000 employees and delivers billions of products annually.